DISTALMOTION Sàrl
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Route De La Corniche Bâtiment Phenyl 3, ...Phone Number
+41 789239334Website
www.distalmotion.comRevenue
$37.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About DISTALMOTION Sàrl
At Distalmotion, our mission is to remove the complexity out of robotic surgery in order to establish a new standard of care, where all patients in general surgery, gynecology and urology have access to best-in-class minimally invasive care.Explore more
DISTALMOTION Sàrl Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DISTALMOTION Sàrl your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on DISTALMOTION Sàrl recently announced quarterly report
DISTALMOTION Sàrl, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once DISTALMOTION Sàrl has new funding data
Click to see if DISTALMOTION Sàrl had a recent Job posting/layoffs
Check out if DISTALMOTION Sàrl is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at DISTALMOTION Sàrl
Product Launch: Get notified when DISTALMOTION Sàrl launches new products
Check if DISTALMOTION Sàrl has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at DISTALMOTION Sàrl
Find 2 more new buyers
Company Profile Activity
Activity Insights
DISTALMOTION Sàrl is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
DISTALMOTION Sàrl is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DISTALMOTION Sàrl.
DISTALMOTION Sàrl financials insights
Gather financial insights about DISTALMOTION Sàrl, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series E
$90M
2023
Other Financing Round
$150M
2025
Series G
$150M
DISTALMOTION Sàrl Tech Stack
A closer look at the technologies used by DISTALMOTION Sàrl
Most Recent Scoops
Hiring Plans
DISTALMOTION Sàrl has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: Salesforce.
Hiring Plans
Open Position
Hiring Plans
DISTALMOTION Sàrl has more open roles in Information Technology than it has had at any time in the past 12 months with an increased focus on technologies like SQL, Tableau, and Python. Areas of expertise include: Data Integrity, ERP Systems Knowledge, Process Engineering, Custom Object, Database Queries, Advanced Analytics, and Data Architecture.
Hiring Plans
Open Position
Open Position
DISTALMOTION Sàrl News & Media
Distalmotion Expands its DEXTER® US Procedural Portfolio to the Top Four Ambulatory Procedures with FDA 510(k) Clearance for Ventral Hernia Repair
Lausanne, Switzerland, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received US Food and Drug Administration 510(k) clearance for ventral hernia repair with its DEXTER Robotic Surgery System. The clearance was supported by data from the Robotic minimAlly invasive Ventral hErNia repair (RAVEN) Study. CE-marked since 2022 in general, gynecologic, and urologic surgery, DEXTER has reDistalmotion Supports ASCs in Expanding GYN Service Lines with US FDA 510(k) Clearance for Additional Gynecology Indications
Lausanne, Switzerland, June 16, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, today announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for sacrocolpopexy, sacrocervicopexy, sacrohysteropexy, and endometriosis resection for the DEXTER® Robotic Surgery System.CORRECTED: Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers
Lausanne, Switzerland, May 21, 2026 (GLOBE NEWSWIRE) -- CORRECTED: Distalmotion, the global MedTech company focused on empowering access to robotic surgery in outpatient settings, announced continued commercial progress in the US, with growing adoption of the DEXTER® Robotic Surgery System across ambulatory surgery centers (ASCs). As more procedures shift out of the hospital, ASCs are seeking practical solutions that address longstanding barriers to robotic adoption such as infrastructure, workfDistalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers
Lausanne, Switzerland, May 21, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company focused on empowering access to robotic surgery in outpatient settings, announced continued commercial progress in the US, with growing adoption of the DEXTER® Robotic Surgery System across ambulatory surgery centers (ASCs). As more procedures shift out of the hospital, ASCs are seeking practical solutions that address longstanding barriers to robotic adoption such as infrastructure, workflow, and co
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DISTALMOTION Sàrl
Sign Up For FreeTo access detailed company insights
At Distalmotion, our mission is to remove the complexity out of robotic surgery in order to establish a new standard of care, where all patients in general surgery, gynecology and urology have access to best-in-class minimally invasive care.... Read More
